Skip to main content
. Author manuscript; available in PMC: 2026 Mar 7.
Published in final edited form as: Am J Gastroenterol. 2025 Mar 7;120(11):2520–2528. doi: 10.14309/ajg.0000000000003383

Table 2.

Socio-demographic and clinical characteristics of those with persistent Barrett’s esophagus (BE) after ultrashort BE on index endoscopy compared to those with a longer BE on index endoscopy.

Persistent BE after USBE on Index Endoscopy (n=86) Longer BE on Index Endoscopy (n=572) p-value
Age at diagnosis (years) 61.5 [SD±8.9] 61.5 [SD±9.1] 0.951
Sex 0.147
 Male 81 (94.2%) 555 (97.0%)
 Female 5 (5.8%) 17 (3.0%)
Mean Follow Up Time (years) 5.95 [SD±9.9] 5.27 [SD±4.7] 0.302
BMI 0.913
 < 25 17 (19.8%) 100 (17.4%)
 25–29.9 34 (39.5%) 228 (39.9%)
 ≥30 35 (40.7%) 242 (42.3%)
 Missing 0 (0.0%) 2 (0.4%)
Race/Ethnicity 0.731
 Non-Hispanic White 69 (80.2%) 463 (80.9%)
 Non-Hispanic Black 6 (7.0%) 51 (8.9%)
 Hispanic 11 (12.8%) 55 (9.6%)
 Missing 0 (0.0%) 3 (0.6%)
Smoking Status 0.193
 Never smoker 17 (19.8%) 156 (27.3%)
 Former smoker 48 (55.8%) 263 (46.0%)
 Current smoker 21 (24.4%) 153 (26.7%)
Alcohol Status 0.202
 Never drinker 29 (33.7%) 230 (40.2%)
 Former drinker 16 (18.6%) 127 (22.2%)
 Current drinker 41 (47.7%) 215 (37.6%)
Hiatal Hernia 0.072
 No 34 (39.5%) 171 (29.9%)
 Yes 52 (60.5%) 401 (70.1%)
PPI or H2RA use 0.312
 No 20 (23.3%) 163 (28.5%)
 Yes 66 (76.7%) 409 (71.5%)

Abbreviations: BE=Barrett’s esophagus. SD=standard deviation. BMI=body mass index. PPI=proton pump inhibitor. H2RA=H2 receptor antagonist.